Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmatrix (PULM) Non-Current Deffered Revenue (2016 - 2023)

Pulmatrix (PULM) has disclosed Non-Current Deffered Revenue for 9 consecutive years, with $3.7 million as the latest value for Q4 2023.

  • Quarterly Non-Current Deffered Revenue fell 22.71% to $3.7 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $3.7 million through Dec 2023, down 22.71% year-over-year, with the annual reading at $3.7 million for FY2023, 22.71% down from the prior year.
  • Non-Current Deffered Revenue hit $3.7 million in Q4 2023 for Pulmatrix, down from $4.0 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $8.0 million in Q3 2020 to a low of $3.7 million in Q4 2023.
  • Historically, Non-Current Deffered Revenue has averaged $5.6 million across 5 years, with a median of $5.4 million in 2021.
  • Biggest five-year swings in Non-Current Deffered Revenue: surged 9558.21% in 2019 and later crashed 32.14% in 2021.
  • Year by year, Non-Current Deffered Revenue stood at $7.9 million in 2019, then decreased by 21.72% to $6.2 million in 2020, then fell by 1.61% to $6.1 million in 2021, then decreased by 20.55% to $4.8 million in 2022, then dropped by 22.71% to $3.7 million in 2023.
  • Business Quant data shows Non-Current Deffered Revenue for PULM at $3.7 million in Q4 2023, $4.0 million in Q3 2023, and $4.3 million in Q2 2023.